Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108658815A reveals a copper-catalyzed synthesis for amino-substituted conjugated enyne aldehydes, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Advanced preparation method for Phenoxybenzamine Hydrochloride via CN102887830B. High-purity pharmaceutical intermediates with optimized cost reduction and scalable manufacturing processes.
Patent CN105755095A enables high-yield enzymatic deracemization. Delivers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel Lewis acid hydrolysis route eliminates explosive isobutylene, ensuring high purity and supply chain safety for peptide synthesis intermediates.
Patent CN102796065A details a novel resolution and cyclization route for S-escitalopram, offering superior optical purity and simplified manufacturing for global pharmaceutical supply chains.
Patent CN107988307A details enzymatic resolution for high-purity intermediates. This method offers significant supply chain reliability and cost reduction in pharmaceutical manufacturing.
Patent CN110256401A reveals silver-catalyzed route. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN113355367B reveals high-efficiency LlKAR enzyme for deracemization. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel benzyl-protected route for Pseudoceramide PMS synthesis. High yield, scalable process for reliable cosmetic ingredient manufacturing and supply.
Patent CN107557412B details a continuous immobilized enzyme method for NADPH synthesis, offering high purity and cost reduction in biopharmaceutical manufacturing.
Patent CN102061103A details a novel anhydride-based synthesis for high-quantum-yield BODIPY dyes, offering streamlined production and superior stability for life science applications.
Novel patent CN115784896A details a safe, high-yield route for 2-bromo-6-fluoroaniline, eliminating explosive azides and ensuring supply chain stability for API manufacturers.
Patent CN102827015A details a novel nitroacetate-based synthesis for ALA HCl, offering cost reduction and scalability for pharmaceutical intermediates without heavy metals.
Novel patent CN104098556A enables high-purity Rivaroxaban intermediate production with reduced costs and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN112125942A reveals a novel chlorination route for Abiraterone Acetate intermediates, offering higher purity and yield compared to traditional iodination methods for scalable manufacturing.
Patent CN119176829B reveals a novel substitution reaction achieving high yield and low impurity. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel microwave synthesis method for dihydrazide phthalazine intermediates offers high purity and cost efficiency for pharmaceutical supply chains globally.
Patent CN106588746B reveals a green hydrogenation route for Gliclazide side chain. Offers high purity, catalyst recycling, and cost reduction for pharmaceutical manufacturing.
Patent CN111004176A reveals a green cobalt-catalyzed route for 2-aryloxy ethanol compounds, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Advanced synthesis of stable Clopidogrel Hydrogen Sulfate Form II via optimized solvent strategy. High purity, reduced waste, and scalable manufacturing for global supply chains.